Clinical Trial Update: Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on multimodal neurobiological markers related to major depressive disorder and anxiety disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Snippet

Sponsor: Medical University of Vienna | Conditions: Major Depressive Disorder (MDD), Anxiety Disorder | Phase 4 | Status: COMPLETED